Hoerter Steven L. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$3.75M

Insider Activity of Hoerter Steven L.

Biography of Hoerter Steven L.

No biography is available at this moment.

2025-10-17PurchaseMBX Biosciences, Inc. Common Stock
MBX
director
20,000
0.0597%
$13.25$264,984+163.99%
2019-03-04SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
5,000
0.0086%
$68.00$340,000-29.6%
2019-03-01SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
5,000
0.0083%
$66.01$330,050-29.78%
2018-08-24SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0035%
$74.92$153,586-25.34%
2018-07-25SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0035%
$84.58$173,389-29.74%
2018-06-22SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0036%
$97.58$200,039-34.45%
2018-05-23SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0034%
$85.76$175,808-26.01%
2018-04-23SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0036%
$85.95$176,198-20.02%
2018-03-22SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0038%
$84.65$173,533-10.67%
2018-02-22SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,050
0.0035%
$78.63$161,192-6.45%
2018-01-23SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
25,000
0.0424%
$74.83$1.87M-0.92%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.